We are live on ! Find out more
Edgewood Management

Edgewood Management Portfolio holdings

AUM $15.5B
1-Year Est. Return 9.67%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+9.67%
3 Year Est. Return
+69.33%
5 Year Est. Return
+71.36%
10 Year Est. Return
+535.67%
AUM
$60.9B
AUM Growth
+$1.35B
Cap. Flow
-$5.69B
Cap. Flow %
-9.34%
Top 10 Hldgs %
51.69%
Holding
88
New
4
Increased
16
Reduced
25
Closed
3

Top Buys

Rank Stock Value
1
SNAP icon
Snap
SNAP
+$1.01B
2
PYPL icon
PayPal
PYPL
+$982M
3
ILMN icon
Illumina
ILMN
+$715M
4
NFLX icon
Netflix
NFLX
+$291M
5
V icon
Visa
V
+$267M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$6.26B
2
NVDA icon
NVIDIA
NVDA
+$1.46B
3
INFO
IHS Markit Ltd. Common Shares
INFO
+$488M
4
AMZN icon
Amazon
AMZN
+$380M
5
INTU icon
Intuit
INTU
+$344M

Sector Composition

Rank Sector Weight
1 Technology 19.84%
2 Financials 19.38%
3 Healthcare 19.08%
4 Communication Services 18.68%
5 Consumer Discretionary 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETG
76
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.75B
$386K ﹤0.01%
17,000
PG icon
77
Procter & Gamble
PG
$336B
$360K ﹤0.01%
2,200
HD icon
78
Home Depot
HD
$338B
$322K ﹤0.01%
777
NEXI
79
DELISTED
NexImmune, Inc. Common Stock
NEXI
$258K ﹤0.01%
2,241
CGNX icon
80
Cognex
CGNX
$9.75B
$240K ﹤0.01%
3,080
LIN icon
81
Linde
LIN
$235B
$231K ﹤0.01%
+666
New +$216K
QCOM icon
82
Qualcomm
QCOM
$169B
$201K ﹤0.01%
+1,100
New +$176K
AXLA
83
DELISTED
Axcella Health Inc. Common Stock
AXLA
$157K ﹤0.01%
3,000
+2,000
+200% +$140K
DNA icon
84
Ginkgo Bioworks
DNA
$498M
$83K ﹤0.01%
250
DNA.WS
85
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$22K ﹤0.01%
10,000
ET icon
86
Energy Transfer Partners
ET
$70.3B
-14,583
Closed -$140K
UAL icon
87
United Airlines
UAL
$39.7B
-4,500
Closed -$214K
DRNA
88
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-25,000
Closed -$504K

Similar funds

Edgewood Management's Q4 2021 Portfolio in Review

As of Q4 2021, Edgewood Management held 88 positions worth $60.9B, up 2.3% from $59.6B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Edgewood Management withdrew a net $5.69B in Q4 2021, closing 3 positions and reducing 25 holdings. Its most notable exit was Dicerna Pharmaceuticals, Inc., an estimated $504K position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Edgewood Management opened a new position in iShares Russell 1000 Growth ETF worth $8.36M.

  • Edgewood Management's largest Q4 2021 buy was iShares Russell 1000 Growth ETF: 109,472 shares worth $8.36M.
  • Edgewood Management added most to Snap in Q4 2021, an estimated $1.01B increase.
  • Edgewood Management's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $6.26B.
  • Edgewood Management fully exited Dicerna Pharmaceuticals, Inc. in Q4 2021, selling an estimated $504K.
  • Edgewood Management's ten largest holdings make up 52% of its $60.9B portfolio in Q4 2021.
  • Edgewood Management opened 4 new positions and closed 3 in Q4 2021.
  • Edgewood Management's portfolio value rose 2.3% quarter-over-quarter to $60.9B.

Based on Edgewood Management's 13F filing for Q4 2021, filed 11 Feb 2022.